Research and Markets: Four Leading Distributors, Casa Marzam, Casa Saba, NADRO and Proveedora de Medicamentos, Dominate the Pharmacy Sector in Mexico.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c37676) has announced the addition of the Espicom Business Intelligence Introduction Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets. report "The Pharmaceutical Market: Mexico" to their offering. The Mexican Mexican named after or originating in Mexico. Mexican axolotl see ambystomamexicanum. Mexican beaded lizard (Heloderma horridum pharmaceutical market is the leading Latin American market and the tenth largest worldwide. International and domestic producers compete in the market and continue to increase exports towards Europe and the USA. Geographically, Mexico can serve the needs of well established pharmaceutical markets such as the USA and Canada, and also the emerging Latin American pharmaceutical markets. New pharmaceutical regulations were enforced in 2005. By updating Article 376 of the General Health Law in January 2005, product registration is no longer unlimited. From now on, it will last for a five-year period. At the same time, bioequivalence bioequivalence /bio·equiv·a·lence/ (-e-kwiv´ah-lens) the relationship between two preparations of the same drug in the same dosage form that have a similar bioavailability. standards are finally fully implemented. This means that copycat products are no longer exempt. Also, the drug classifications will be reduced to four categories. As a result, the market is expected to shift. Bioequivalent bi·o·e·quiv·a·lent n. A value indicating the rate at which a substance enters the bloodstream and becomes available to the body. generics, which represented around 2.7% of the pharmacy pharmacy, art of compounding and dispensing drugs and medication. The term is also applied to an establishment used for such purposes. Until modern times medication was prepared and dispensed by the physician himself. In the 18th cent. sector in 2003, are expected to increase their share in 2006, taking over most of the sector left by copycats, which accounted for 10.3% in 2003. For research-based products, the only competitors will be bioequivalent generics. Further regulation is also expected regarding over-the-counter (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). ) switching and advertising. The growth of 'miracle products' has tarnished the OTC sector. However, OTC advertising was further regulated in 2005, which means that many 'miracle products' will be withdrawn from the market. Overall, the OTC sector should increase in 2006, fuelled by more consumer demand. Distribution channels are becoming more competitive. Four leading distributors, Casa Marzam, Casa Saba, NADRO and Proveedora de Medicamentos, dominate the pharmacy sector. Casa Saba and NADRO alone account for 60%. They are using their monopoly to their advantage and are starting to demand higher wholesale margins, which is perceived as anti-competitive by producers. This report comprises four main sections: Pharma Market Outlook, Background Data, Healthcare System, and Accessing the Pharmaceutical Market. The Outlook section provides analysis of the market and five-year market forecasts, national data projections and key market developments. Other sections provide a wealth of background and market access information, including pharmaceutical regulation, pricing & reimbursement Reimbursement Payment made to someone for out-of-pocket expenses has incurred. , population trends, morbidity and mortality Morbidity and Mortality can refer to:
n. Medical care provided to outpatients. ambulatory care, n the health services provided on an outpatient basis to those who can visit a health care facility and return home the same day. , medical personnel, trade data and essential industry contacts. Companies mentioned: --Casa Marzam --Casa Saba --NADRO --Proveedora de Medicamentos For more information visit http://www.researchandmarkets.com/reports/c37676 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion